-
Shufang Medicine assists Xiangya Second Hospital in launching the first 5D smart diagnosis and treatment center for pulmonary hypertension in China
Time of Update: 2021-10-11
The pictures are: Zhang Chao, founder and CEO of Left Hand Doctor, Li Jiang, Director of Pulmonary and Vascular Disease Subspecialty, Department of Cardiology, Second Xiangya Hospital of Central South University, Yan Zhiyu, Chairman of Shufang Medicine, Xu Qing, Head of Innovative Business Development, Li Dongxue, Product Manager, and Xiangya, Central South University Luo Jun, Attending Physician, Department of Cardiology, Ya Second HospitalAI empowers a new model of doctor-patient connectionPulmonary hypertension is a rare and fatal cardiopulmonary vascular disease.
-
Chinese scholars found organic molecular residues in ancient dinosaur cell nuclei
Time of Update: 2021-10-11
In the Jehol Biota in the western Liaoning region of northeast China, a team of scientists discovered well-preserved chondrocytes in the tail feather dragon fossils 125 million years ago; team members discovered some chondrocytes that were “fossilized” in a healthy state, and some Chondrocytes that are about to die; the nucleus of these cells may also contain filamentous chromatin, and more accurate tests are needed to further determine the biochemical properties of these cells .
-
Potential "first-in-class" therapy released latest data analysis
Time of Update: 2021-10-11
The results of the analysis showed that in patients with severe asthma who had uncontrolled symptoms with nasal polyps, the addition of tezepelumab reduced the exacerbation rate by 86% compared with placebo while receiving standard treatment .
Reference materials:[1] New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps.
-
Determination of potential factors leading to severe new coronary pneumonia
Time of Update: 2021-10-11
High levels of CD47 protein can prevent an effective immune response, increase disease-related tissue and organ damage, or cause a higher severity of new coronary pneumonia .
Researchers have discovered that the new coronavirus infects cells and causes the level of a protein called CD47 on the cell surface to increase .
-
An imperfect vaccine is also the best strategy for epidemic prevention-historical enlightenment from the 1918 pandemic
Time of Update: 2021-10-11
So, can scientists who are at a loss for pathogens create a "useful" vaccine during the pandemic?At that time, the medical profession paid particular attention to the observation of the validity that determines the direction of vaccine development .
-
First-line treatment of gastroesophageal adenocarcinoma HER2 targeting bispecific antibody achieves 90.9% disease control rate
Time of Update: 2021-10-11
Today, Zymeworks announced that it is investigating zanidatamab, a bispecific antibody therapy targeting HER2, and has achieved positive results in a first-line clinical trial for the treatment of HER2-expressing gastroesophageal adenocarcinoma (GEA) patients .
Retrieved September 12, 2021, from https:// news/home/20210912005060/en[2] Zymeworks Corporate Presentation.
-
Innovent announces that the Phase 2 clinical study of IBI112 (IL-23 monoclonal antibody) for the treatment of moderate to severe plaque psoriasis has completed the first subject administration
Time of Update: 2021-10-11
A biopharmaceutical company, an innovative drug for major diseases, today announced that its recombinant anti-interleukin 23p19 subunit antibody injection (development code: IBI112) will be used in a phase 2 clinical trial of patients with moderate to severe plaque psoriasis (clinicaltrials.
-
Bojian Vumerity is recommended by EU CHMP for the treatment of multiple sclerosis
Time of Update: 2021-10-11
CompilationTom LeeA few days ago, the European Commission for Medicinal Products for Human Use (CHMP) announced the recommendation of Bojian Vumerity (diroximelfumarate) for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS) .
-
The world's first new crown DNA vaccine approved: 67% effective against Delta strain
Time of Update: 2021-10-11
Article source: Medical Rubik's Cube ProAuthor: HaimerAccording to a report by Nature on September 2, the Indian drug regulatory agency approved the world's first DNA vaccine ZyCoV-D to prevent new crown infections in people 12 years and older .
-
Immune cells cooperate to prey on bacteria
Time of Update: 2021-10-11
According to a study published in the journal "Science Advances" on the 11th, researchers from the Vanderbilt University Medical Center in the United States have discovered a new antibacterial mechanism of immune cells, which helps to develop new strategies against Staphylococcus aureus and other pathogens .
-
LSO Medical Corporation Announces CE Approval of Next Generation Lumeseal Laser Treatment of Varicose Veins
Time of Update: 2021-10-11
Learjet, September 24, 2021 /PRNewswire/ - LSO MEDICAL SAS, an international leader in vascular laser therapy, today announced that its latest generation EVLT SnakeBack® assist system LUMESEAL laser platform has received CE approval .
-
Chinese scholars have made important breakthroughs in the research of ultra-small and high-performance luminescent nanoparticles
Time of Update: 2021-10-11
An important breakthrough has been made in the field of nano-luminescent materials . Black big offerChina News Service, Harbin, September 15 (Reporter Yifu Shi) Heilongjiang University announced on
-
Significantly reduce pain and improve function. Innovative treatment for osteoarthritis Phase 3 clinical results are positive
Time of Update: 2021-10-11
Reference materials:[1] Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK).
Retrieved September 15, 2021, from https:// news-releases/ampio-pharmaceuticals-announces-top-line-results-from-ap-013-phase-iii-study-of-ampion-in-adult-patients-suffering-from-severe-osteoarthritis-of-the- knee-oak-301377453.
-
Innovative oral therapy to improve lung function in selected moderate to severe asthma patients announced the latest phase 2 trial results
Time of Update: 2021-10-11
On September 7, 2021, Knopp Biosciences announced the further clinical and biomarker data of dexpramipexole, a phase 2 clinical trial of EXHALE in patients with moderate to severe eosinophilic asthma .
-
Positive results of Agenus anti-PD-1 monoclonal antibody for treatment of refractory cervical cancer stage 2
Time of Update: 2021-10-11
On August 26, 2021, Agenus announced that its anti-PD-1 monoclonal antibody batilimumab (balstilimab), a single-drug treatment of recurrent/metastatic cervical cancer, was published online in the international peer-reviewed journal.
-
Tumor treatment field obtains breakthrough status for liver cancer
Time of Update: 2021-10-11
newsnewsToday, the Israeli company Novocure announced that its tumor treatment field (TTF) treatment device NovoTTF-200T combined with the PD-L1 drug Tecentriq and the angiogenesis inhibitor Avastin has obtained the FDA's breakthrough status in the first-line treatment of advanced liver cancer .
-
Salt can suppress tumors by increasing immune cells!
Time of Update: 2021-10-11
They found that the number of bifidobacteria in mice with high salt content increased, which led to an increase in the types of immune cells that attack cancer tumors.
-
These cutting-edge black technologies will appear at the World Internet Conference
Time of Update: 2021-10-11
On September 15, the Zhejiang Provincial Department of Economy and Information Technology held a press conference to "spoiler" the highlights of important events during the conference, such as the much-watched "Light of the Internet" Expo and the "Direct Wuzhen" Global Internet Competition .
-
It turns out to be contagious!
Time of Update: 2021-10-11
Is there any cure for congenital deficiency of teeth and calcium supplementation?The results of the fourth national oral health epidemiological survey showed that the average number of dental caries among adolescents and children aged 3, 4, 5, 12, and 15 were 2 (2.
-
The international community should carry out traceability of the new coronavirus in many countries and places
Time of Update: 2021-10-11
For example, a retrospective survey study in The Lancet on January 24, 2020 showed that among the first batch of 41 cases of new coronary pneumonia confirmed by laboratories in Wuhan from December 16, 2019 to January 2, 2020 , The earliest case of symptoms can be traced back to December 1, 2019, and the patient has no history of exposure to the South China Seafood Market .
